Schizophrenia Clinical Trial
Official title:
Randomized Controlled Study on the Efficacy of the NECT Program (Cognitive Therapy and Narrative Development) on Improving Social Functioning in People With Severe Psychic Disorders
Self-stigma refers to the transformation process wherein a person's previously held social
identity is progressively replaced by a devalued and stigmatized view of oneself termed
"illness identity". Self-Stigma is a severe problem in Serious Mental Illness (SMI).
Self-stigma prevalence is high (41.7% of the 1229 participants with SZ and 21.7% of the 1182
participants with mood disorders had moderate to high levels of IS in the GAMIAN-Europe
study). Self-stigma was negatively associated with self-esteem, social function, wellbeing,
quality of life or personal recovery and positively associated with psychiatric symptoms and
depression. Several psychosocial interventions (mostly combinations of psychoeducation and
cognitive behaviour therapy) have been designed to reduce self-stigma and its impact on
clinical and functional outcomes, with preliminary effects on self-stigma, insight and
self-efficacy.
Narrative Enhancement and Cognitive Therapy (NECT) is a manualized structured 20-session
group-based intervention . Conducted by two trained facilitators the sessions combine
psychoeducation, cognitive restructuring and story-telling exercises to reduce self-stigma.
Developed in USA, NECT was adapted in Israel and Sweden. NECT showed effectiveness in
reducing self-stigma and in improving self-esteem and quality of life. Despite being
effective on changing coping strategies, NECT effectiveness on social function is still
unclear.
The present study aims to validate NECT French adaptation and to evaluate its effectiveness
on social function, self-stigma, psychiatric symptoms, self-esteem, wellbeing, quality of
life and personal recovery in SMI participants (schizophrenia, bipolar disorder, borderline
personality disorder)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |